Searchable abstracts of presentations at key conferences in endocrinology

ea0051s3.2 | Diabetes Track 1: Symposium 3 | BSPED2017

Insulin Pump Therapy: What is the Evidence?

Blair Jo

Introduction: Intensive insulin treatment regimens, multiple daily injections (MDI) and continuous subcutaneous insulin infusions (CSII) are used widely in the NHS, despite a lack of evidence that more expensive treatment with CSII is superior to MDI. In this presentation, data from previous observational and interventional studies will be reviewed. The findings of the SCIPI study (SubCuntaneous Insulin: Pumps or Injections?), which compared the effectiveness, safety, quality ...

ea0086ns1.3 | Neuroendocrine tumours | SFEBES2022

Patient perspective of multiple endocrine neoplasia syndromes

Grey Jo

AMEND provides information resources and support services to families with MEN syndromes, offering free membership, educational and peer support events, and a free Counselling Service provided by rare disease specialist psychotherapy organisation, Rareminds. Our 2021 Counselling Service feedback data (n=24) showed that the biggest issue by far for patients is dealing with their diagnosis (39% of respondents). Managing symptoms and treatment are also significant issues...

ea0016s28.2 | GH: structure–function relationship | ECE2008

The contribution of autocrine human growth hormone to neoplasia

Lobie Peter , Perry Jo

The hGH gene is expressed in epithelial cells of the normal human mammary gland. Increased epithelial expression of the hGH gene is associated with the acquisition of pathological proliferation, and the highest level of hGH gene expression is observed in metastatic mammary carcinoma cells. Autocrine hGH production in human mammary carcinoma cells results in increased cell proliferation and survival associated with alterations in morphology. We have further demonstrated that au...

ea0050p185 | Clinical Biochemistry | SFEBES2017

Development of a sensitive, rapid LC-MS/MS method for detection of oxytocin in human plasma

Bernstone Laura , Adaway Jo , Keevil Brian

Oxytocin is a peptide hormone consisting of 9 amino acids, with a mass of 1007 Da. It is synthesised in the hypothalamus and secreted from the posterior pituitary. It has well known roles in lactation and uterine contraction, however it is also thought to act within the brain to influence complex social behaviours such as bonding, empathy, and trust. Recently there has been increasing interest in the potential role of oxytocin in the pathophysiology...

ea0050p185 | Clinical Biochemistry | SFEBES2017

Development of a sensitive, rapid LC-MS/MS method for detection of oxytocin in human plasma

Bernstone Laura , Adaway Jo , Keevil Brian

Oxytocin is a peptide hormone consisting of 9 amino acids, with a mass of 1007 Da. It is synthesised in the hypothalamus and secreted from the posterior pituitary. It has well known roles in lactation and uterine contraction, however it is also thought to act within the brain to influence complex social behaviours such as bonding, empathy, and trust. Recently there has been increasing interest in the potential role of oxytocin in the pathophysiology...

ea0044p164 | Neuroendocrinology and pituitary | SFEBES2016

Investigation of the appearance of adenohypophyseal folliculostellate cells during embryonic chick development

Talintyre Iona , Begbie Jo , Christian Helen

Folliculostellate (FS) cells constitute around 10% of the adenohypophyseal cell population. Various functions of these non-endocrine cells have been elucidated, including the paracrine control of the function of local endocrine cells. FS cell development is currently very poorly understood. In this study FS cell appearance during embryonic chick development between pre-natal stages (st)17-37 was examined. Gene and protein expression of the FS marker proteins annexin A1 (AnxA1)...

ea0032p361 | Diabetes | ECE2013

Type 2 diabetes and prostate cancer risk in Korean men with low PSA

Kimm Heejin , Jo Jaeseong , Jee Sun Ha

Introduction: Diabetes as a risk factor of cancer should be explored further. The value of PSA is limited because we cannot exclude prostate cancer in lower PSA levels. We analyzed diabetes and the risk of prostate cancer in lower PSA in a large cohort study.Method: A total of 179 456 health examinees (men, aged 30–89 years) from 1994 to 2010 were participated. Participants with any cancer or potential prostate diseases were excluded from analysis. ...

ea0013p238 | Neuroendocrinology and behaviour (including pituitary) | SFEBES2007

The effect of exogenous estradiol administration on working memory in the ovariectomised female hooded-lister rat

Sutcliffe Jane , Neill Jo , Marshall Kay

The aim of the investigation was to evaluate the effect exogenous of 17-β-estradiol propionate (E2) on working memory as assessed by the novel object recognition (NOR) paradigm following intermittent or delayed E2 regimens.15 rats were ovariectomised under anaesthesia and were divided into 3 groups namely: (1) vehicle (2) intermittent E2 dosing weeks 1–6 and 13–18, with no treatment weeks 7–12 and (3) delayed (no treatment in weeks 1&...

ea0045p69 | Pituitary and growth | BSPED2016

Changes in Height and IGF-I SDS in the first year of GH treatment are related to BMI SDS

Price Victoria , Blair Jo , Hawcutt Dan

Background: During childhood, growth hormone (GH) doses are usually calculated using total body weight (TBW). This may result in inappropriately high doses in obese children where the intravascular compartment does not increase in proportion with the increase in weight, as the volume of distribution of GH is consistent with the majority of the drug being distributed in the total body water compartment.Methods: Single centre, retrospective cohort study of...

ea0070aep473 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Refeeding syndrome – an unexpected clinical case

Puga Francisca , Baptista Patrícia , França Margarida , Araújo Correia João

Refeeding syndrome can be defined as the potentially fatal shift in fluids and electrolytes that may occur after the reintroduction of feeding after a period of starvation or fasting in malnourished patients. The hallmark characteristic of refeeding syndrome is hypophosphatemia. However, the syndrome is complex and may also feature abnormal sodium and fluid balance, changes in glucose, protein and fat metabolism, hypokalemia, hypomagnesemia and thiamine deficiency. The underly...